Previous studies demonstrated that RCAN1 played an inhibitory role in the progression of some gastrointestinal cancers, like hepatocellular carcinoma (HCC), pancreatic carcinoma, and colorectal carcinoma. This evidence concerns the gene RCAN1 and hepatocellular carcinoma.